Gustavsson B, Eklöf C, Westermark K, Westermark B, Heldin N E
Department of Pathology, University Hospital, Uppsala, Sweden.
Mol Cell Endocrinol. 1995 Jun;111(2):167-73. doi: 10.1016/0303-7207(95)03562-l.
Nucleotide sequence analysis of PCR fragments corresponding to the TSH-receptor (TSHR) amplified from genomic DNA collected from the four members of a family, two of which had Graves' thyrotoxicosis, revealed a nucleotide substitution in the first position of codon 36 of the TSH-receptor gene in the two patients. The nucleotide substitution was from G to C, leading to a 36D-->36H change (D36H) in the predicted amino acid sequence of the receptor. The altered sequence was also found in DNA obtained from their mother, but not in DNA from their father. We stably expressed the two receptor variants in NIH 3T3 cells, by transfection of cDNA encoding the wildtype (WT) and D36H variants of the TSHR. Neither the binding of 125I-TSH nor the responsiveness to TSH measured as cAMP formation, appeared to be different in the TSHR-D36H compared to the TSHR-WT. Furthermore, the D36H-receptor also became desensitized when exposed to TSH as did the WT-receptor.
对从一个家族的四名成员采集的基因组DNA中扩增出的促甲状腺激素受体(TSHR)对应的PCR片段进行核苷酸序列分析,该家族中有两名成员患有格雷夫斯甲状腺毒症。结果显示,两名患者的TSH受体基因第36密码子的第一位发生了核苷酸替换。该核苷酸替换从G变为C,导致受体预测氨基酸序列中发生36D→36H变化(D36H)。在从他们母亲获得的DNA中也发现了改变的序列,但在他们父亲的DNA中未发现。通过转染编码TSHR野生型(WT)和D36H变体的cDNA,我们在NIH 3T3细胞中稳定表达了这两种受体变体。与TSHR-WT相比,TSHR-D36H中125I-TSH的结合以及以cAMP形成衡量的对TSH的反应性似乎没有差异。此外,与WT受体一样,D36H受体在暴露于TSH时也会脱敏。